---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-056922"
form_type: "8-K"
ticker: "NAMS"
cik: "0001936258"
company_name: "NewAmsterdam Pharma Co N.V."
filed_at: "2024-03-04T23:59:59+00:00"
generated_at: "2026-06-05T05:03:53.865584+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# NewAmsterdam Pharma posts updated investor presentation; no material new data

## Summary
- Company posted updated corporate investor presentation on its website on March 4, 2024.
- Presentation contains no new financial results, guidance, or material operational updates.
- No earnings, M&A, or clinical data disclosed in the filing or exhibit.
- Routine update typical for investor relations purposes.

## SEC filing metadata
- accession: 0001193125-24-056922
- form_type: 8-K
- ticker: NAMS
- cik: 0001936258
- company_name: NewAmsterdam Pharma Co N.V.
- filed_at: 2024-03-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1936258/000119312524056922/0001193125-24-056922-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1936258/000119312524056922/d759933d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-056922
- JSON: https://secwatch.observer/filing/0001193125-24-056922.json
- Plain text: https://secwatch.observer/filing/0001193125-24-056922.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.